(2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-((7-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-5-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid

Catalog No. :
ACGGDN526
CAS No. :
952414-48-1
Molecular Formula :
C21H18O11
Molecular Weight :
446.36

IUPAC Name:(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-((7-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-5-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid

(2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-((7-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-5-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-((7-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-5-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
IUPAC Name(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-((7-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-5-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
Molecular FormulaC21H18O11
Molecular Weight446.36
SMILESO=C([C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC2=CC(O)=CC3=C2C(C=C(C4=CC=C(O)C=C4)O3)=O)O1)O
InChI KeyFNSVTQFRLNQDTR-ZFORQUDYSA-N
SynonymApigenin 5-O-β-D-Glucuronide;(3S,4S,5S,6S)-3,4,5-Trihydroxy-6-(7-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-5-yloxy)-tetrahydro-2H-pyran-2-carboxylic acid;β-D-Glucopyranosiduronic acid, 7-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-5-yl
CAS No.952414-48-1

Synthetic Route by SureRoute

1. ACGGDN526 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGGDN526 route product structure diagram
    ACGGDN526952414-48-1
Inquiry

2. ACGGDN526 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGGDN526 route product structure diagram
    ACGGDN526952414-48-1
Inquiry

Comments (0)